EligibleTrials

Evaluation of PWI Assisted by Marshall Ethanolization in Ablation of Persistent Atrial Fibrillation

Recruiting · NCT06363604 · Interventional (participants receive a specific treatment) · Lead sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

Posterior wall isolationVOMEI + PVI + linear ablation of mitral isthmus

What this trial is about

This is a prospective, randomized controlled, single-blind, multi-center clinical trial study aiming to investigate whether the strategy of posterior wall isolation (PWI) assisted by vein of Marshall ethanol infusion (VOMEI) could improve the success rate of persistent atrial fibrillation ablation.

Who can take part

Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.